NAMSW Financial Model

Quarterly and annual income statement, cash flow and balance sheet line items for NewAmsterdam Pharma Company N.V. Warrant: revenue, gross and operating margin, EBITDA, free cash flow, buybacks, cash, debt and shares outstanding. Latest statement: Dec 31, 2024.

NAMSW – NewAmsterdam Pharma Company N.V. Warrant stock overview